Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

[Clinical features of familial non-medullary thyroid cancer patients].

Zhang X, An C, Wan H, Zhang Z, Liu W, Li Z, Xu Z, Tang P.

Zhonghua Zhong Liu Za Zhi. 2014 Jan;36(1):69-73. Chinese.

PMID:
24685091
2.

[Clinical and biological features of familial nonmedullary thyroid carcinoma].

Gao J, Yu Y, Li X, Zhao J, Zhao C, Zhao J, Liu Y, Li Y, Gao M.

Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):202-6. Chinese.

PMID:
24785281
3.

Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.

Capezzone M, Marchisotta S, Cantara S, Busonero G, Brilli L, Pazaitou-Panayiotou K, Carli AF, Caruso G, Toti P, Capitani S, Pammolli A, Pacini F.

Endocr Relat Cancer. 2008 Dec;15(4):1075-81. doi: 10.1677/ERC-08-0080. Epub 2008 Oct 2.

4.

The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.

Park YJ, Ahn HY, Choi HS, Kim KW, Park do J, Cho BY.

Thyroid. 2012 Apr;22(4):356-62. doi: 10.1089/thy.2011.0163. Epub 2012 Jan 26.

5.

Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.

Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Yamashita H, Shuto S.

World J Surg. 2002 Aug;26(8):897-902. Epub 2002 Apr 30.

PMID:
11965446
6.

Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.

Alsanea O, Wada N, Ain K, Wong M, Taylor K, Ituarte PH, Treseler PA, Weier HU, Freimer N, Siperstein AE, Duh QY, Takami H, Clark OH.

Surgery. 2000 Dec;128(6):1043-50;discussion 1050-1.

PMID:
11114641
7.

In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.

Mazeh H, Benavidez J, Poehls JL, Youngwirth L, Chen H, Sippel RS.

Thyroid. 2012 Jan;22(1):3-8. doi: 10.1089/thy.2011.0192. Epub 2011 Dec 2.

PMID:
22136209
8.

Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma.

Uchino S, Noguchi S, Yamashita H, Murakami T, Watanabe S, Ogawa T, Tsuno A, Shuto S.

World J Surg. 2004 Nov;28(11):1099-102.

PMID:
15490050
9.

Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.

Lee YM, Yoon JH, Yi O, Sung TY, Chung KW, Kim WB, Hong SJ.

J Surg Oncol. 2014 Feb;109(2):168-73. doi: 10.1002/jso.23447. Epub 2013 Oct 16.

PMID:
24132694
10.

[Biological characteristics and management of familial papillary thyroid carcinoma].

Zhao J, Yu Y, Xia TT, Liu YZ, Wei SF, Zheng XQ, Gao M.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Nov;46(11):897-900. Chinese.

PMID:
22335974
11.

Familial non-medullary thyroid cancer: a matched-case control study.

Maxwell EL, Hall FT, Freeman JL.

Laryngoscope. 2004 Dec;114(12):2182-6.

PMID:
15564841
12.

Familial thyroid cancer.

Alsanea O, Clark OH.

Curr Opin Oncol. 2001 Jan;13(1):44-51. Review.

PMID:
11148685
13.

Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment.

Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH.

Arch Surg. 1995 Aug;130(8):892-7; discussion 898-9. Review.

PMID:
7632152
14.

Clinicopathologic features of familial nonmedullary thyroid carcinoma.

Fan YF, Zhang B, Yang X, Shang ZH, Liu HF, Xie Y, Liu YW, Gao WS, Wu Q, Li XY.

Chin Med J (Engl). 2015 Apr 20;128(8):1037-41. doi: 10.4103/0366-6999.155075.

15.

An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.

Sippel RS, Caron NR, Clark OH.

World J Surg. 2007 May;31(5):924-33. Review.

PMID:
17429563
16.
17.

Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.

Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH.

World J Surg. 2013 Feb;37(2):376-84. doi: 10.1007/s00268-012-1835-2.

PMID:
23135422
18.

Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour.

Pinto AE, Silva GL, Henrique R, Menezes FD, Teixeira MR, Leite V, Cavaco BM.

Eur J Endocrinol. 2013 Dec 21;170(2):321-7. doi: 10.1530/EJE-13-0865. Print 2014 Feb.

19.

[Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].

Lin YK, Sheng JM, Zhao WH, Wang WB, Yu XF, Teng LS, Ma ZM.

Zhonghua Wai Ke Za Zhi. 2009 Mar 15;47(6):450-3. Chinese.

PMID:
19595234
20.

Patients with familial non-medullary thyroid cancer have an outcome similar to that of patients with sporadic papillary thyroid tumors.

Pitoia F, Cross G, Salvai ME, Abelleira E, Niepomniszcze H.

Arq Bras Endocrinol Metabol. 2011 Apr;55(3):219-23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk